SCHEMBL9997488

SCHEMBL9997488

CCc1ccc(C=C(COC(C)=O)C(C)C)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 1/20 0.41
KMT2A Q03164 6/20 0.38
MAPT P10636 5/20 0.38
MEN1 O00255 5/20 0.38
NPSR1 Q6W5P4 4/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
ALDH1A1 P00352 6/20 0.36
HPGD P15428 4/20 0.36
LMNA P02545 4/20 0.36
KDM4E B2RXH2 2/20 0.36
PKM P14618 1/20 0.36
ALOX12 P18054 1/20 0.36
MCL1 Q07820 1/20 0.36
ATM Q13315 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
MAOB P27338 1/20 0.36
MAOA P21397 1/20 0.36
CYP1A2 P05177 1/20 0.35
CYP2C9 P11712 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9998162 0.88 THRB (0.40) KMT2AMAPTNPSR1SMN1; SMN2ALDH1A1
SCHEMBL9997809 0.86 ALDH1A1 (0.42) MAPTNPSR1SMN1; SMN2ALDH1A1HPGD
SCHEMBL9997642 0.85 THRB (0.44) KMT2AMEN1ALDH1A1TDP1CYP1A2
SCHEMBL9998404 0.84 LMNA (0.42) AKR1C3KMT2AMAPTMEN1NPSR1
SCHEMBL9997794 0.84 THRB (0.44) KMT2AMEN1ALDH1A1TDP1CYP1A2
SCHEMBL9998230 0.84 THRB (0.44) KMT2AMEN1ALDH1A1TDP1CYP1A2
SCHEMBL9997494 0.84 THRB (0.44) KMT2AMEN1ALDH1A1TDP1CYP1A2
SCHEMBL9998437 0.84 THRB (0.44) KMT2AMEN1ALDH1A1TDP1CYP1A2
SCHEMBL9998279 0.84 THRB (0.44) KMT2AMEN1ALDH1A1TDP1CYP1A2
SCHEMBL9998250 0.83 KDM4E (0.42) KMT2AMAPTMEN1SMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8558012-B2 2-fluoro-1,3-benzodithiol 1,1,3,3-tetraoxide derivative, production method thereof, and production method of monofluoromethyl group-containing compound using the same NAGOYA INSTITUTE OF TECHNOLOGY (JP) 2013-10-15 US disclosed
US-20110319637-A1 2-FLUORO-1,3-BENZODITHIOL 1,1,3,3-TETRAOXIDE DERIVATIVE, PRODUCTION METHOD THEREOF, AND PRODUCTION METHOD OF MONOFLUOROMETHYL GROUP-CONTAINING COMPOUND USING THE SAME NAGOYA INSTITUTE OF TECHNOLOGY (JP) 2011-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110319637-A1 2-FLUORO-1,3-BENZODITHIOL 1,1,3,3-TETRAOXIDE DERIVATIVE, PRODUCTION METHOD THEREOF, AND PRODUCTION METHOD OF MONOFLUOROMETHYL GROUP-CONTAINING COMPOUND USING THE SAME CBR1, CYP1B1, CYP2F1 AKR1C3 291/4885KMT2A 2324/4885MAPT 2206/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.